Modulation Of the Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise with PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/18/Austin/206
SSA Reference Number: SSA/40604/MonH-2018-153039
Monash Health HREC Ref: RES-18-0000-634X
StatusFinished
Effective start/end date8/03/19 → 7/03/24

Clinical Trial Phase

  • Phase II